<VariationArchive VariationID="3062113" VariationName="NM_014712.3(SETD1A):c.2121dup (p.Gly708fs)" VariationType="Duplication" Accession="VCV003062113" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-23" DateCreated="2024-03-23" MostRecentSubmission="2024-03-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3222341" VariationID="3062113">
      <GeneList>
        <Gene Symbol="SETD1A" FullName="SET domain containing 1A, histone lysine methyltransferase" GeneID="9739" HGNC_ID="HGNC:29010" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="30957754" stop="30984664" display_start="30957754" display_stop="30984664" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="30968614" stop="30995980" display_start="30968614" display_stop="30995980" Strand="+" />
          </Location>
          <OMIM>611052</OMIM>
          <Haploinsufficiency last_evaluated="2018-02-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SETD1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-02-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SETD1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_014712.3(SETD1A):c.2121dup (p.Gly708fs)</Name>
      <CanonicalSPDI>NC_000016.10:30965995:CCCCCCC:CCCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="30965995" stop="30965996" display_start="30965995" display_stop="30965996" variantLength="1" positionVCF="30965995" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="30977316" stop="30977317" display_start="30977316" display_stop="30977317" variantLength="1" positionVCF="30977316" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>G708fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.30966002dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.30966002dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.30977323dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.30977323dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_052948.1" sequenceAccession="NG_052948" sequenceVersion="1" change="g.13709dup">
            <Expression>NG_052948.1:g.13709dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014712.3" sequenceAccession="NM_014712" sequenceVersion="3" change="c.2121dup" MANESelect="true">
            <Expression>NM_014712.3:c.2121dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055527.1" sequenceAccession="NP_055527" sequenceVersion="1" change="p.Gly708fs">
            <Expression>NP_055527.1:p.Gly708fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014712.3(SETD1A):c.2121dup (p.Gly708fs) AND Neurodevelopmental disorder with speech impairment and dysmorphic facies" Accession="RCV003985223" Version="1">
        <ClassifiedConditionList TraitSetID="57037">
          <ClassifiedCondition DB="MedGen" ID="C5436699">Neurodevelopmental disorder with speech impairment and dysmorphic facies</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-03-23" MostRecentSubmission="2024-03-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="57037" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="54558" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder with speech impairment and dysmorphic facies</ElementValue>
                <XRef ID="MONDO:0033630" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NEDSID</ElementValue>
                <XRef Type="MIM" ID="619056" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18530" />
                <XRef ID="18530" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C5436699" DB="MedGen" />
              <XRef ID="MONDO:0033630" DB="MONDO" />
              <XRef Type="MIM" ID="619056" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8977686" SubmissionDate="2024-03-19" DateLastUpdated="2024-03-23" DateCreated="2024-03-23">
        <ClinVarSubmissionID localKey=":Chr.16_30977316_30977316_G_GC|OMIM:619056" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004801582" DateUpdated="2024-03-23" DateCreated="2024-03-23" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SETD1A c.2121dupC p.(Gly708ArgfsTer117) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. The variant has been identified in an individual with a phenotype consistent with neurodevelopmental disorder with speech impairment and dysmorphic facies (Singh et al. 2016). The variant was also identified in the parent of this individual, though the affected status and phenotype of the parent are not provided. This variant is not reported in version 2.1.1 or version 3.1.1 of the Genome Aggregation Database. The variant was identified in a de novo state in the proband. Based on the available evidence, the c.2121dupC p.(Gly708ArgfsTer117) variant is classified as pathogenic for neurodevelopmental disorder with speech impairment and dysmorphic facies.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSLVariantClassificationCriteria RUGD 01 April 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/dy7elfgy/icslvariantclassificationcriteria_rugd_01_april_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="GC" referenceAllele="G" start="30977316" stop="30977316" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619056" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14324016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8977686" TraitType="Disease" MappingType="XRef" MappingValue="619056" MappingRef="OMIM">
        <MedGen CUI="C5436699" Name="Neurodevelopmental disorder with speech impairment and dysmorphic facies" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

